IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Imunon, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 11, 2026
$0.98−0.04 (-3.43%)
Close on Oct 19, 2026
- Market cap
- $4.95M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
–FY2025